Weighted Average Number of Shares Outstanding, Basic of Oncternal Therapeutics, Inc. from 31 Dec 2013 to 30 Sep 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Oncternal Therapeutics, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Dec 2013 to 30 Sep 2024.
  • Oncternal Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2024 was 2,960,000, a 0.41% increase year-over-year.
  • Oncternal Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 2,940,000, a 12% increase from 2022.
  • Oncternal Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 2,630,000, a 95% decline from 2021.
  • Oncternal Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 49,321,000.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Oncternal Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 2,960,000 +12,000 +0.41% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 2,960,000 +24,000 +0.82% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 2,959,000 +33,000 +1.1% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 2,940,000 +310,000 +12% 01 Oct 2023 31 Dec 2023 10-K 07 Mar 2024 2023 FY
Q3 2023 2,948,000 -51,264,000 -95% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 2,936,000 -47,128,000 -94% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 2,926,000 -46,503,000 -94% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 2,630,000 01 Oct 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 54,212,000 +4,819,000 +9.8% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 50,064,000 +700,000 +1.4% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 49,429,000 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q3 2021 49,393,000 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 49,364,000 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q4 2017 21,541,909 +5,828,699 +37% 01 Oct 2017 31 Dec 2017 10-K 13 Mar 2018 2017 FY
Q3 2017 16,115,835 +1,926,609 +14% 01 Jul 2017 30 Sep 2017 10-K 13 Mar 2018 2017 FY
Q2 2017 16,041,923 +1,867,009 +13% 01 Apr 2017 30 Jun 2017 10-K 13 Mar 2018 2017 FY
Q1 2017 16,018,342 +1,866,138 +13% 01 Jan 2017 31 Mar 2017 10-K 13 Mar 2018 2017 FY
Q4 2016 15,713,210 +1,675,799 +12% 01 Oct 2016 31 Dec 2016 10-K 13 Mar 2018 2017 FY
Q3 2016 14,189,226 +151,815 +1.1% 01 Jul 2016 30 Sep 2016 10-K 13 Mar 2018 2017 FY
Q2 2016 14,174,914 +137,503 +0.98% 01 Apr 2016 30 Jun 2016 10-K 13 Mar 2018 2017 FY
Q1 2016 14,152,204 +118,617 +0.84% 01 Jan 2016 31 Mar 2016 10-K 13 Mar 2018 2017 FY
Q4 2015 14,037,411 01 Oct 2015 31 Dec 2015 10-K 24 Mar 2017 2016 FY
Q3 2015 14,037,411 -61,977,120 -82% 01 Jul 2015 30 Sep 2015 10-K 24 Mar 2017 2016 FY
Q2 2015 14,037,411 01 Apr 2015 30 Jun 2015 10-K 24 Mar 2017 2016 FY
Q1 2015 14,033,587 01 Jan 2015 31 Mar 2015 10-K 24 Mar 2017 2016 FY
Q3 2014 76,014,531 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015 2015 Q3

Oncternal Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 2,940,000 +310,000 +12% 01 Jan 2023 31 Dec 2023 10-K 07 Mar 2024 2023 FY
2022 2,630,000 -46,691,000 -95% 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
2021 49,321,000 01 Jan 2021 31 Dec 2021 10-K 09 Mar 2023 2022 FY
2017 17,441,280 +2,881,739 +20% 01 Jan 2017 31 Dec 2017 10-K 13 Mar 2018 2017 FY
2016 14,559,541 +523,073 +3.7% 01 Jan 2016 31 Dec 2016 10-K 13 Mar 2018 2017 FY
2015 14,036,468 +5,855,698 +72% 01 Jan 2015 31 Dec 2015 10-K 13 Mar 2018 2017 FY
2014 8,180,770 -54,876,372 -87% 01 Jan 2014 31 Dec 2014 10-K 24 Mar 2017 2016 FY
2013 63,057,142 01 Jan 2013 31 Dec 2013 10-K 15 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.